Molecular docking approach of monoamine oxidase B inhibitors for identifying new potential drugs: Insights into drug-protein interaction discovery

Molecular docking approach of monoamine oxidase B inhibitors for identifying new potential drugs: Insights into drug-protein interaction discovery

Monoamine oxidase (EC, 1.4.3.4) or amine oxidoreductase catalyzes the oxidative deamination of biogenic amines. Abnormal action of the monoamine oxidase B has been associated with neurological dysfunctions including parkinson´s disorder. Monoamine oxidase B inhibitors divulged that these agents were...

Full description

Bibliographic Details
Main Author:	Salimeh Raeisi
Format:	Article
Language:	English
Published:	Ferdowsi University of Mashhad 2013-11-01
Series:	Journal of Cell and Molecular Research
Subjects:	monoamine oxidase b inhibitor parkinson´s disorder molecular docking binding free energy
Online Access:	https://jcmr.um.ac.ir/article_26907_4a305ce8b0bcfcae26092921127eac8e.pdf

Similar Items

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
by: Makoto Naoi, et al.
Published: (2022-09-01)

Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors
by: Nisha Abdul Rehuman, et al.
Published: (2022-09-01)

Role of Monoamine Oxidase Activity in Alzheimer’s Disease: An Insight into the Therapeutic Potential of Inhibitors
by: Tapan Behl, et al.
Published: (2021-06-01)

The inhibition of monoamine oxidase by harmine derivatives
by: Theo Myburg, et al.
Published: (2022-01-01)

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles
by: Miguel Pinto, et al.
Published: (2019-07-01)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
by: Reem Aljanabi, et al.
Published: (2021-10-01)

Selective Interactions of <i>O</i>-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B
by: Narayan D. Chaurasiya, et al.
Published: (2020-11-01)

Computational Insights into β-Carboline Inhibition of Monoamine Oxidase A
by: Alja Prah, et al.
Published: (2022-10-01)

Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation
by: Arshida Thottile Peedikayil, et al.
Published: (2023-10-01)

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
by: Jong Min Oh, et al.
Published: (2020-05-01)

Microbial Metabolite Urolithin B Inhibits Recombinant Human Monoamine Oxidase A Enzyme
by: Rajbir Singh, et al.
Published: (2020-06-01)

Colorimetric dopamine detection based on immobilized monoamine oxidase through silver nanoparticles
by: Shin, Gounhanul, et al.
Published: (2023)

Performance of Force-Field- and Machine Learning-Based Scoring Functions in Ranking MAO-B Protein–Inhibitor Complexes in Relevance to Developing Parkinson’s Therapeutics
by: Natarajan Arul Murugan, et al.
Published: (2020-10-01)

From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs
by: Giulia Nordio, et al.
Published: (2023-08-01)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
by: Wiem Haj Ahmed, et al.
Published: (2020-04-01)

Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid
by: Chung-Chieh Hung, et al.
Published: (2024-01-01)

Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
by: Jiseong Lee, et al.
Published: (2024-01-01)

Allelic Diversity of VNTR Polymorphism in Monoamine Oxidase A (MAOA) Gene in Young Women and Men in Mashhad, Iran
by: Sedigheh Sadat Hojjati, et al.
Published: (2020-02-01)

Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach
by: Aathira Sujathan Nair, et al.
Published: (2021-05-01)

Monoamine Oxidase Inhibitors Prevent Glucose-Dependent Energy Production, Proliferation and Migration of Bladder Carcinoma Cells
by: Jessica Resta, et al.
Published: (2022-10-01)

Screening of Monoamine Oxidase Inhibitors from Seeds of <i>Nigella glandulifera</i> Freyn et Sint. by Ligand Fishing and Their Neuroprotective Activity
by: Emmanuel Ayodeji Ayeni, et al.
Published: (2023-02-01)

Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors
by: Vedanjali Gogineni, et al.
Published: (2021-09-01)

Monoamine Oxidase Inhibition by Major Tanshinones from <i>Salvia miltiorrhiza</i> and Selective Muscarinic Acetylcholine M<sub>4</sub> Receptor Antagonism by Tanshinone I
by: Ritu Prajapati, et al.
Published: (2021-07-01)

Medicarpin and Homopterocarpin Isolated from <i>Canavalia lineata</i> as Potent and Competitive Reversible Inhibitors of Human Monoamine Oxidase-B
by: Jong Min Oh, et al.
Published: (2022-12-01)

How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
by: Anne Wurzlbauer, et al.
Published: (2020-12-01)

Apigenin attenuates depressive-like behavior via modulating monoamine oxidase A enzyme activity in chronically stressed mice
by: Juliet N. Olayinka, et al.
Published: (2023-01-01)

Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation
by: Alan F. Sved, et al.
Published: (2022-08-01)

Computer-aided approach for the identification of lead molecules as the inhibitors of cholinesterase’s and monoamine oxidases: Novel target for the treatment of Alzheimer disease
by: Ejaz Syeda Abida, et al.
Published: (2024-01-01)

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
by: Huang ST, et al.
Published: (2024-01-01)

(<i>S</i>)-<i>N</i>-Benzyl-1-phenyl-3,4-dihydroisoqunoline-2(1<i>H</i>)-carboxamide Derivatives, Multi-Target Inhibitors of Monoamine Oxidase and Cholinesterase: Design, Synthesis, and Biological Activity
by: Qing-Hao Jin, et al.
Published: (2023-02-01)

Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease
by: Amritha Manoharan, et al.
Published: (2023-08-01)

Pannorin isolated from marine Penicillium sp. SG-W3: a selective monoamine oxidase A inhibitor
by: Jong Min Oh, et al.
Published: (2024-03-01)

β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
by: Tomás Herraiz
Published: (2023-03-01)

Selected Class of Enamides Bearing Nitro Functionality as Dual-Acting with Highly Selective Monoamine Oxidase-B and BACE1 Inhibitors
by: Anusree Venkidath, et al.
Published: (2021-10-01)

<i>N</i>-Hydroxy-<i>N</i>-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
by: Óscar M. Bautista-Aguilera, et al.
Published: (2022-11-01)

Green Oxidation of Amines by a Novel Cold-Adapted Monoamine Oxidase MAO P3 from Psychrophilic Fungi <i>Pseudogymnoascus</i> sp. P3
by: Iga Jodłowska, et al.
Published: (2021-10-01)

Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors
by: Sunil Kumar, et al.
Published: (2024-02-01)

Enantioselective Interactions of Anti-Infective 8-Aminoquinoline Therapeutics with Human Monoamine Oxidases A and B
by: Narayan D. Chaurasiya, et al.
Published: (2021-04-01)

4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B
by: Tjaša Mazej, et al.
Published: (2021-07-01)